{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:18:51Z","timestamp":1786997931515,"version":"build-2736575974"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological and Toxicological Methods"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.vascn.2022.107167","type":"journal-article","created":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T22:58:47Z","timestamp":1647298727000},"page":"107167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Nonclinical cardiovascular safety assessment of thioridazine: Impact of autonomic tone, body temperature, and choice of species"],"prefix":"10.1016","volume":"115","author":[{"given":"Andrea","family":"Greiter-Wilke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Heinig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Waiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Jenni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Holzgrefe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"82\u201386","key":"10.1016\/j.vascn.2022.107167_bb0005","first-page":"5","article-title":"Central nervous system kinetics of atenolol and metoprolol in the dog during long term treatment","volume":"17","author":"Abrahamsson","year":"1989","journal-title":"Drug Metabolism and Disposition"},{"issue":"487\u2013500","key":"10.1016\/j.vascn.2022.107167_bb0010","first-page":"5","article-title":"QT PRODACT: In vivo QT assay with a conscious monkey for assessment of the potential for drug-induced QT interval prolongation","volume":"99","author":"Ando","year":"2005","journal-title":"Journal of Pharmacological Sciences"},{"issue":"994","key":"10.1016\/j.vascn.2022.107167_bb0015","first-page":"5","article-title":"Individually rate corrected QTc intervals in children and adolescents","volume":"10","author":"Andrsova","year":"2019","journal-title":"Frontiers in Physiology"},{"key":"10.1016\/j.vascn.2022.107167_bib334","author":"Anonymous"},{"issue":"967\u2013974","key":"10.1016\/j.vascn.2022.107167_bb0030","first-page":"5","article-title":"Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein binding","volume":"92","author":"Banker","year":"2003","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"1338\u20131343","key":"10.1016\/j.vascn.2022.107167_bb0035","first-page":"5","article-title":"Exercise effect on canine and miniswine cardiac catecholamines and enkephalins","volume":"29","author":"Barron","year":"1997","journal-title":"Medicine and Science in Sports and Exercise"},{"issue":"530\u2013541","key":"10.1016\/j.vascn.2022.107167_bb0040","first-page":"5","article-title":"Confounders and pharmacological characterization when using the QT, JTp, and Tpe intervals in beagle dogs","volume":"39","author":"Boulay","year":"2020","journal-title":"International Journal of Toxicology"},{"key":"10.1016\/j.vascn.2022.107167_bb0045","series-title":"Goodman & Gilman\u2019s: The pharmacological basis of therapeutics","author":"Brunton","year":"2018"},{"issue":"465\u2013470","key":"10.1016\/j.vascn.2022.107167_bb0050","first-page":"5","article-title":"Sensitivity and reliability of halothane-anaesthetized Microminipigs to assess risk of drug-induced long QT syndrome","volume":"121","author":"Cao","year":"2017","journal-title":"Basic & Clinical Pharmacology & Toxicology"},{"key":"10.1016\/j.vascn.2022.107167_bb0055","author":"CDER"},{"key":"10.1016\/j.vascn.2022.107167_bib331","author":"CDER"},{"key":"10.1016\/j.vascn.2022.107167_bib332","author":"CDER"},{"issue":"601\u2013612","key":"10.1016\/j.vascn.2022.107167_bb0065","first-page":"5","article-title":"The high frequency relationship: Implications for torsadogenic hERG blockers","volume":"173","author":"Champeroux","year":"2016","journal-title":"British Journal of Pharmacology"},{"issue":"73\u201385","key":"10.1016\/j.vascn.2022.107167_bb0070","first-page":"5","article-title":"Calculation of QT shift in non clinical safety pharmacology studies","volume":"59","author":"Champeroux","year":"2009","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"251\u2013263","key":"10.1016\/j.vascn.2022.107167_bb0075","first-page":"5","article-title":"Interferences of the autonomic nervous system with drug induced QT prolongation: A point to consider in non-clinical safety studies","volume":"61","author":"Champeroux","year":"2010","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"269\u2013278","key":"10.1016\/j.vascn.2022.107167_bb0080","first-page":"5","article-title":"A step towards characterisation of electrophysiological profile of torsadogenic drugs","volume":"63","author":"Champeroux","year":"2011","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"88\u2013103","key":"10.1016\/j.vascn.2022.107167_bb0085","first-page":"5","article-title":"Pharmaceutical toxicology: Designing studies to reduce animal use, while maximizing human translation","volume":"66","author":"Chapman","year":"2013","journal-title":"Regulatory Toxicology and Pharmacology"},{"issue":"103\u2013114","key":"10.1016\/j.vascn.2022.107167_bb0090","first-page":"5","article-title":"A highly sensitive canine telemetry model for detection of QT interval prolongation: Studies with moxifloxacin, haloperidol and MK-499","volume":"56","author":"Chaves","year":"2007","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"1133\u20131143","key":"10.1016\/j.vascn.2022.107167_bb0095","first-page":"5","article-title":"Effects of antipsychotic drugs on I(to), I (Na), I (sus), I (K1), and hERG: QT prolongation, structure activity relationship, and network analysis","volume":"23","author":"Crumb","year":"2006","journal-title":"Pharmaceutical Research"},{"issue":"522\u2013531","key":"10.1016\/j.vascn.2022.107167_bb0100","first-page":"5","article-title":"Are women more susceptible than men to drug-induced QT prolongation? Concentration-QTc modelling in a phase 1 study with oral rac-sotalol","volume":"77","author":"Darpo","year":"2014","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"610\u2013615","key":"10.1016\/j.vascn.2022.107167_bb0105","first-page":"5","article-title":"Analysis of statistical tests to compare doses of analgesics among groups","volume":"81","author":"Dexter","year":"1994","journal-title":"Anesthesiology"},{"key":"10.1016\/j.vascn.2022.107167_bb0110","first-page":"143","article-title":"Partitioning of thioridazine and mesoridazine in human blood fractions","volume":"6","author":"Dinovo","year":"1984","journal-title":"Methods and Findings in Experimental and Clinical Pharmacology"},{"issue":"2819\u20132832","key":"10.1016\/j.vascn.2022.107167_bb0115","first-page":"5","article-title":"Pharmacokinetic-pharmacodynamic modelling of drug-induced QTc interval prolongation in man: Prediction from in vitro human ether-a-go-go-related gene binding and functional inhibition assays and conscious dog studies","volume":"173","author":"Dubois","year":"2016","journal-title":"British Journal of Pharmacology"},{"issue":"123\u2013130","key":"10.1016\/j.vascn.2022.107167_bb0120","first-page":"5","article-title":"Effect of beta-adrenoceptor blockers on human ether-a-go-go-related gene (HERG) potassium channels","volume":"96","author":"Dupuis","year":"2005","journal-title":"Basic & Clinical Pharmacology & Toxicology"},{"issue":"136\u2013143","key":"10.1016\/j.vascn.2022.107167_bb0125","first-page":"5","article-title":"QT interval correction for drug-induced changes in body temperature during integrated cardiovascular safety assessment in regulatory toxicology studies in dogs: A case study","volume":"81","author":"El Amrani","year":"2016","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"1587\u20131596","key":"10.1016\/j.vascn.2022.107167_bb0130","first-page":"5","article-title":"Electrophysiological mechanisms of antiarrhythmic protection during hypothermia in winter hibernating versus nonhibernating mammals","volume":"5","author":"Fedorov","year":"2008","journal-title":"Heart Rhythm"},{"issue":"319\u2013322","key":"10.1016\/j.vascn.2022.107167_bb0135","first-page":"5","article-title":"Studies on thioridazine and mesoridazine metabolism. I. Protein binding","volume":"3","author":"Forrest","year":"1979","journal-title":"Communications in Psychopharmacology"},{"issue":"310\u2013319","key":"10.1016\/j.vascn.2022.107167_bb0140","first-page":"5","article-title":"beta-adrenergic blockade in cardiovascular disease","volume":"18","author":"Frishman","year":"2013","journal-title":"Journal of Cardiovascular Pharmacology and Therapeutics"},{"issue":"H44\u201350","key":"10.1016\/j.vascn.2022.107167_bb0145","first-page":"5","article-title":"Parasympathetic inhibition of sympathetic effects on sinus rate in anesthetized dogs","volume":"271","author":"Furukawa","year":"1996","journal-title":"The American Journal of Physiology"},{"issue":"52\u201358","key":"10.1016\/j.vascn.2022.107167_bb0150","first-page":"5","article-title":"The comparative sensitivity of three in vitro safety pharmacology models for the detection of lidocaine-induced cardiac effects","volume":"66","author":"Goineau","year":"2012","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"e12699","key":"10.1016\/j.vascn.2022.107167_bb0155","first-page":"5","article-title":"Clinically significant incidental QTc prolongation is subject to within-individual variability","volume":"25","author":"Gueta","year":"2020","journal-title":"Annals of Noninvasive Electrocardiology"},{"issue":"130\u2013151","key":"10.1016\/j.vascn.2022.107167_bb0160","first-page":"5","article-title":"Validation of a guinea pig Langendorff heart model for assessing potential cardiovascular liability of drug candidates","volume":"60","author":"Guo","year":"2009","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"15\u201322","key":"10.1016\/j.vascn.2022.107167_bb0165","first-page":"5","article-title":"Statistical analysis for toxicity studies","volume":"31","author":"Hamada","year":"2018","journal-title":"Journal of Toxicologic Pathology"},{"issue":"471\u2013480","key":"10.1016\/j.vascn.2022.107167_bb0170","first-page":"5","article-title":"Antipsychotic-related fatal poisoning, England and Wales, 1993-2013: Impact of the withdrawal of thioridazine","volume":"54","author":"Handley","year":"2016","journal-title":"Clinical Toxicology (Philadelphia, Pa.)"},{"issue":"116\u2013129","key":"10.1016\/j.vascn.2022.107167_bb0175","first-page":"5","article-title":"ILSI-HESI cardiovascular safety subcommittee initiative: Evaluation of three non-clinical models of QT prolongation","volume":"54","author":"Hanson","year":"2006","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"260\u2013273","key":"10.1016\/j.vascn.2022.107167_bb0180","first-page":"5","article-title":"On the relationship between block of the cardiac Na(+) channel and drug-induced prolongation of the QRS complex","volume":"164","author":"Harmer","year":"2011","journal-title":"British Journal of Pharmacology"},{"issue":"543\u2013553","key":"10.1016\/j.vascn.2022.107167_bb0185","first-page":"5","article-title":"Concentration-related pharmacodynamic effects of thioridazine and its metabolites in humans","volume":"60","author":"Hartigan-Go","year":"1996","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"100\u2013105","key":"10.1016\/j.vascn.2022.107167_bb0190","first-page":"5","article-title":"Thioridazine toxicity--an experimental cardiovascular study of thioridazine and its major metabolites in overdose","volume":"27","author":"Heath","year":"1985","journal-title":"Veterinary and Human Toxicology"},{"issue":"61\u2013101","key":"10.1016\/j.vascn.2022.107167_bb0195","first-page":"5","article-title":"Preclinical QT safety assessment: Cross-species comparisons and human translation from an industry consortium","volume":"69","author":"Holzgrefe","year":"2014","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"186\u2013195","key":"10.1016\/j.vascn.2022.107167_bb0200","first-page":"5","article-title":"Characterization of cardiac repolarization in the Gottingen minipig","volume":"63","author":"Laursen","year":"2011","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"67\u201383","key":"10.1016\/j.vascn.2022.107167_bb0205","first-page":"5","article-title":"Simultaneous determination of bosentan and its three major metabolites in various biological matrices and species using narrow bore liquid chromatography with ion spray tandem mass spectrometric detection","volume":"749","author":"Lausecker","year":"2000","journal-title":"Journal of Chromatography. B, Biomedical Sciences and Applications"},{"issue":"113\u2013122","key":"10.1016\/j.vascn.2022.107167_bb0210","first-page":"5","article-title":"Cardiovascular side-effects of antipsychotic drugs: The role of the autonomic nervous system","volume":"135","author":"Leung","year":"2012","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/j.vascn.2022.107167_bb0215","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.3109\/00498259309059422","article-title":"Metabolism of piperidine-type phenothiazine antipsychotic agents. IV. Thioridazine in dog, man and rat","volume":"23","author":"Lin","year":"1993","journal-title":"Xenobiotica"},{"issue":"1474\u20131481","key":"10.1016\/j.vascn.2022.107167_bb0220","first-page":"5","article-title":"The effect of changes in core body temperature on the QT interval in beagle dogs: A previously ignored phenomenon, with a method for correction","volume":"154","author":"van der Linde","year":"2008","journal-title":"British Journal of Pharmacology"},{"issue":"1232\u20131241","key":"10.1016\/j.vascn.2022.107167_bb0225","first-page":"5","article-title":"ICH E14-compatible holter bin method and its equivalence to individual heart rate correction in the assessment of drug-induced QT changes","volume":"25","author":"Malik","year":"2014","journal-title":"Journal of Cardiovascular Electrophysiology"},{"issue":"368\u2013376","key":"10.1016\/j.vascn.2022.107167_bb0230","first-page":"5","article-title":"Protein binding-dependent decreases in hERG channel blocker potency assessed by whole-cell voltage clamp in serum","volume":"55","author":"Margulis","year":"2010","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"79\u201387","key":"10.1016\/j.vascn.2022.107167_bb0235","first-page":"5","article-title":"Validation of the normal, freely moving Gottingen minipig for pharmacological safety testing","volume":"60","author":"Markert","year":"2009","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"627\u2013631","key":"10.1016\/j.vascn.2022.107167_bb0240","first-page":"5","article-title":"Hypothermia following antipsychotic drug use","volume":"63","author":"van Marum","year":"2007","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"249\u2013261","key":"10.1016\/j.vascn.2022.107167_bb0245","first-page":"5","article-title":"Pharmacokinetic studies with atenolol in the dog","volume":"4","author":"McAinsh","year":"1983","journal-title":"Biopharmaceutics & Drug Disposition"},{"issue":"40\u201344","key":"10.1016\/j.vascn.2022.107167_bb0250","first-page":"5","article-title":"The influence of chlormethiazole in comparison to thioridazine on body temperature and postural hypotension in healthy adults and healthy elderly volunteers","volume":"329","author":"McCarthy","year":"1986","journal-title":"Acta Psychiatrica Scandinavica. Supplementum"},{"issue":"402\u2013405","key":"10.1016\/j.vascn.2022.107167_bb0255","first-page":"5","article-title":"Imipramine and thioridazine: Lack of peripheral effects","volume":"28","author":"McKinney","year":"1967","journal-title":"Diseases of the Nervous System"},{"issue":"1548","key":"10.1016\/j.vascn.2022.107167_bb0260","first-page":"5","article-title":"Beat-to-beat patterning of sinus rhythm reveals non-linear rhythm in the dog compared to the human","volume":"10","author":"Moise","year":"2019","journal-title":"Frontiers in Physiology"},{"issue":"171\u2013182","key":"10.1016\/j.vascn.2022.107167_bb0265","first-page":"5","article-title":"Shortening of the electromechanical window in the ketamine\/xylazine-anesthetized guinea pig model to assess pro-arrhythmic risk in early drug development","volume":"81","author":"Morissette","year":"2016","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"105029","key":"10.1016\/j.vascn.2022.107167_bb0270","first-page":"5","article-title":"Species selection for nonclinical safety assessment of drug candidates: Examples of current industry practice","volume":"126","author":"Namdari","year":"2021","journal-title":"Regulatory Toxicology and Pharmacology"},{"issue":"66\u201371","key":"10.1016\/j.vascn.2022.107167_bb0275","first-page":"5","article-title":"Effect of autonomic blockade on ventricular repolarization shortening: Response to behavioral stimulus in paced dogs","volume":"140","author":"Nolan","year":"2008","journal-title":"Autonomic Neuroscience"},{"issue":"1013\u20131019","key":"10.1016\/j.vascn.2022.107167_bb0280","first-page":"5","article-title":"Individual-specific QT interval correction for drugs with substantial heart rate effect using Holter ECGs extracted over a wide range of heart rates","volume":"58","author":"Panicker","year":"2018","journal-title":"Journal of Clinical Pharmacology"},{"issue":"1227\u20131231","key":"10.1016\/j.vascn.2022.107167_bb0285","first-page":"5","article-title":"Outcome of patients after market withdrawal of thioridazine: A retrospective analysis in a nationwide cohort","volume":"21","author":"Purhonen","year":"2012","journal-title":"Pharmacoepidemiology and Drug Safety"},{"key":"10.1016\/j.vascn.2022.107167_bb0290","first-page":"5","article-title":"Cardiovascular effects of verapamil in the G\u00f6ttingen minipig","volume":"93 (Abstract), 218","author":"Roberts","year":"2018","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"376\u2013382","key":"10.1016\/j.vascn.2022.107167_bb0295","first-page":"5","article-title":"Individualized corrected QT interval is superior to QT interval corrected using the Bazett formula in predicting mutation carriage in families with long QT syndrome","volume":"14","author":"Robyns","year":"2017","journal-title":"Heart Rhythm"},{"issue":"548\u2013554","key":"10.1016\/j.vascn.2022.107167_bb0300","first-page":"5","article-title":"Comparison of the effects of thioridazine and mesoridazine on the QT interval in healthy adults after single oral doses","volume":"82","author":"Salih","year":"2007","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"159\u2013165","key":"10.1016\/j.vascn.2022.107167_bb0305","first-page":"5","article-title":"Single dose pharmacodynamics of thioridazine and remoxipride in healthy younger and older volunteers","volume":"13","author":"Swift","year":"1999","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.vascn.2022.107167_bb0310","first-page":"5","article-title":"Assessment of the relationship between core body temperature and QT\/QTc in the minipig using Dihydrocapsaicin","volume":"66 (Abstract), 184","author":"Tang","year":"2012","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2022.107167_bib333","author":"Anonymous"},{"issue":"459\u2013471","key":"10.1016\/j.vascn.2022.107167_bb0315","first-page":"5","article-title":"QT PRODACT: In vivo QT assay in the conscious dog for assessing the potential for QT interval prolongation by human pharmaceuticals","volume":"99","author":"Toyoshima","year":"2005","journal-title":"Journal of Pharmacological Sciences"},{"issue":"H313\u2013316","key":"10.1016\/j.vascn.2022.107167_bb0320","first-page":"5","article-title":"Autonomic modulation of atrioventricular conduction in ouabain-treated dogs","volume":"254","author":"Wallick","year":"1988","journal-title":"The American Journal of Physiology"},{"issue":"161\u2013166","key":"10.1016\/j.vascn.2022.107167_bb0325","first-page":"5","article-title":"Pharmacophore modeling for hERG channel facilitation","volume":"418","author":"Yamakawa","year":"2012","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.vascn.2022.107167_bb0330","doi-asserted-by":"crossref","first-page":"337. 5","DOI":"10.3389\/fphar.2018.00337","article-title":"A chimeric NaV1.8 channel expression system based on HEK293T cell line","volume":"9","author":"Zhou","year":"2018","journal-title":"Frontiers in Pharmacology"}],"updated-by":[{"DOI":"10.1016\/j.vascn.2026.108559","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000}},{"DOI":"10.1016\/j.vascn.2026.108559","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000}}],"container-title":["Journal of Pharmacological and Toxicological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871922000144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871922000144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:05:00Z","timestamp":1761005100000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056871922000144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":67,"alternative-id":["S1056871922000144"],"URL":"https:\/\/doi.org\/10.1016\/j.vascn.2022.107167","relation":{},"ISSN":["1056-8719"],"issn-type":[{"value":"1056-8719","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nonclinical cardiovascular safety assessment of thioridazine: Impact of autonomic tone, body temperature, and choice of species","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological and Toxicological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vascn.2022.107167","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107167"}}